📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response (2024)

First Author: Drennan P

Attributed to: Cellular immunity and genetic restriction of Influenza, Hepatitis C virus infection and Hepatitis B associated heptocellular carcinoma. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4955295

Publication URI: http://dx.doi.org/10.2139/ssrn.4955295

Type: Preprint